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Background: Improvements in patient-reported health-related quality of life (HRQoL) are important goals of cardiac
rehabilitation (CR). In patients undergoing coronary angiography for angina and with documented coronary artery
disease (CAD), the present study compared HRQoL over 6 months in CR participants and non-participants. Clinical
predictors of CR participants were also assessed.
Methods: A total of 221 consecutive patients undergoing angiography for angina with documented CAD and who
were eligible for a CR program were recruited. CR participants were enrolled in a six-week Phase II outpatient CR
course (31%, n = 68) within 2 months following angiography and the non-participants were included as a control.
At baseline (angiography), one and six months post angiography, clinical and HRQoL data were obtained including
the Short Form-36 (SF-36) and the Seattle Angina Questionnaire (SAQ). The response rate for the HRQoL assessment
was 68% (n = 150). Cross sectional comparisons were age-adjusted and performed using logistic or linear regression
as appropriate. Longitudinal changes in HRQoL were assessed using least squares regression. Finally, a multiple
logistic regression was fitted with CR participant as the final outcome.
Results: At angiography, the CR non-participants were older, and age-adjusted analyses revealed poorer physical
(angina limitation: 54 ± 25 versus 64 ± 22, p <0.05) and mental HRQoL (significant psycho-social distress: 62%, n = 95
versus 47%, n = 32, p <0.05) compared to the CR participants. In addition, the CR participants were more likely to
have undergone angiography for myocardial infarction (OR = 2.8, 95% CI 1.5-5.3, p = 0.001). By six months, all
patients showed an improvement in HRQoL indices, however the rate of improvement did not differ between the
controls and CR participants.
Conclusion: Following angiography, CAD patients reported improvements in both generic and disease-specific
HRQoL, however CR participation did not influence this outcome. This may be explained by biases in CR
enrollment, whereby acute patients, who may be less limited in HRQoL compared to stable, chronic patients, are
targeted for CR participation. Further investigation is required so CR programs maximize the quality of life benefits
to all potential CR patients.
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Cardiac rehabilitation (CR) programs are recognized as
an effective component for the management of patients
with coronary artery disease (CAD) [1,2]. Two system-
atic reviews of almost 50 randomised controlled trials
showed a 20% reduction in all cause mortality and a 27%
reduction in cardiac mortality at two to five years [3,4].* Correspondence: john.beltrame@adelaide.edu.au
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distribution, and reproduction in any mediumHowever, the impact of CR on health-related quality of
life (HRQoL) has been inconclusive [4] due to the
limited studies and the methodologies employed.
Previous CR studies have largely targeted patients with a
recent MI, coronary revascularisation or cardiac failure.
However all patients with CAD could potentially benefit
from CR, especially those with chronic diseases who are
more likely to be significantly disabled. Despite this, it
appears that patients with chronic angina are less likely to
participate in these programs [5], especially if they are fe-
male [6] or do not undergo revascularisation procedures.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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angiography to ascertain (i) the clinical characteristics and
HRQoL of patients undergoing CR as compared to those
who do not, (ii) to assess the clinical predictors of CR
participants, and (iii) compare the 6-month HRQoL
progress following angiography in those that do and do
not receive CR.
Methods
This prospective, observational study recruited patients
undergoing diagnostic angiography at the Queen Elizabeth
Hospital (QEH) (Adelaide, Australia) between April 2003
and May 2007 and followed their progress over a 6-month
period. The QEH is a tertiary hospital that provides
cardiac care to the North-Western suburbs of Adelaide as
well as diagnostic angiographic facilities for rural communi-
ties and smaller metropolitan hospitals. The Hospital pro-
vides Phase II CR services only for those patients residing
within its local health care jurisdiction. This study was
approved by the Central Northern Adelaide Health Service
Ethics of Human Research Committee.
Study patients
Inclusion criteria for study enrollment included patients
presenting for (i) invasive coronary angiography undertaken
for the investigation of chest pain, (ii) angiographically
documented obstructive CAD (≥ 50% stenosis in at least
one epicardial coronary artery), and (iii) eligibility for Phase
II CR at QEH (defined by residential location in the
Western suburbs of Adelaide, Australia).
The study exclusion criteria were (a) non-coronary
disorders such as aortic valve disease, and (b) inability to
communicate in English/unable to complete written
questionnaires.
Cardiac rehabilitation program
The QEH Phase II CR program comprises of biweekly
visits held over a 6-week period. The course incorporates
counseling and education on overall heart health and risk
factor identification, nutrition, smoking cessation and
weight loss. In addition, relaxation techniques and stress
management for both patients and their partners or carers
are included. A structured exercise program with an
individualized exercise prescription was incorporated into
each session.
Study protocol
Patients scheduled for coronary angiography for the
investigation of chest pain were approached prior to the
procedure and informed consent was obtained. At this
time, a detailed clinical history was attained via standar-
dized medical case-note review (conducted by clinical
nurses and medical staff ). At time of consent, all patients
underwent a short interview with clinical nurses or trainedresearch assistants assessing cardiovascular risk profile,
and angina severity which was graded according to the
Canadian Cardiovascular Society Classification (CCSC).
This was followed by HRQoL assessment utilizing the self-
administered Short-Form 36 (SF-36) [7] and the Seattle
Angina Questionnaires (SAQ) [8] instruments. At 1 and
6 months post-angiography, patients were re-assessed by:
(a) SF-36 and SAQ mailed out for completion, (b) review
of hospital administrative system for hospital admissions/
presentations and (2) follow-up phone calls made assessing
angina status, medication use and clinical events.
Parameters assessed
Participation in CR was strictly defined as completion of
the Phase II CR program as identified by the hospital CR
services medical record system. The CR records were
reviewed to identify patients who were documented as
having completed the CR program at the hospital. The
CR records at a second hospital, outside the local health
care jurisdiction, were also reviewed to verify if any
patients included in the study underwent CR at another
nearby facility. Clinical data was obtained by medical
case note review and patient interview. Socio-economic
status was defined by the Australian Bureau of Statistics’
Socio-Economic Indexes for Areas scores, an accepted
proxy measure for socio-economic status based on
regional analyses in Australia [9]. HRQoL was assessed
using both a generic (SF-36) and disease specific (SAQ)
questionnaire. The SF-36 is a well-established measure
[7], and has been shown to have good reliability, validity
and responsiveness in patients with CAD [10], and also
in a CR setting [11]. Elevated psychosocial distress was
identified by the SF-36 Mental Summary Score (MCS) of
≤45 [12]. The SAQ is a disease-specific functional status
measure quantifying five clinically relevant domains
related to angina: physical limitation, angina stability,
angina frequency, treatment satisfaction & quality of life
[8]. It is reported to be the most appropriate disease-
specific instrument for CAD [13].
Statistical analysis
Comparisons were made between patients who completed
the Phase II CR program and those who did not partici-
pate in the program. Cross-sectional analyses between the
CR participants and non-participants, for categorical or
continuous variables were performed using either logistic
or linear regression respectively, and age adjusted where
appropriate. Longitudinal changes in SF-36 and SAQ
scores from baseline to 6 months between the CR groups
were compared utilising either random effects generalised
least square or fixed effects ordinary least squares regres-
sion [14]. A multiple logistic regression was fitted with CR
attendance as the final outcome. Variables identified for
the multivariate analysis were selected following univariate
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was obtained using automatic backward elimination, and
the final odds ratios (ORs) with 95% CIs and p values are
reported. All analyses were performed with STATA
(Version 11, StataCorp, Texas, USA).
Missing HRQoL data management
Follow-up HRQoL data over the 6 months was available
in 68% of patients undergoing coronary angiography. To
account for possible missing value bias, multiple imputation
techniques [15] were used, conditioned upon the available
SAQ and SF-36 scores. Imputation was performed by
chained equations utilising switching regression, an iterative
multivariable regression technique [16]. The data analysis
was then repeated using the above-described methods but
no significant deviation from the original models were
observed. The HRQoL results presented below are those
from the imputed data analysis.
Results
Between 28th April 2003 and 11th April 2007, 828
patients with angiographic evidence of CAD were identified
and consented. Of these, 221 (27%) were eligible for referral
to TQEH Phase II cardiac rehabilitation services and were
recruited into the study. Figure 1 shows the Study Flow
Diagram. Of these patients, 68 (31%) participated and
completed the Phase II CR with almost 70% (n = 46)
commencing the program within one month of coronary
angiography. The mean waiting time for enrolment was
1.7 months (SD = 2.15, 95% CI 1.16-2.22).
Baseline characteristics of study patients
Demographic and clinical features
Patients attending Phase II CR were significantly
younger compared to patients who did not attend CR
and thus subsequent analyses were age-adjusted. In
relation to socioeconomic status, 24% (n = 37) of CR
patients were identified as belonging to low, which was
comparable to 16% (n = 11) in the CR non-participants
(Table 1). The CR patients were more likely to have under-
gone angiography following an admission with an acute
coronary syndrome (ACS) (Table 2), with 41% (n = 62)
having experienced a recent myocardial infarction com-
pared with 17% (n = 12) who did not have CR (p < 0.001).
Despite this, the extent of angiographic disease was similar
between groups as was the initial therapy although there
was a slight trend towards medical therapy for those not
participating in CR (Table 2).
HRQoL indices
Scores on the HRQoL indices indicated the CR patients
had a better quality of life in terms of both general
health status and angina-specific morbidity at baseline
(Table 2). Scores on the physical limitation domain ofthe SAQ were significantly higher in the CR patients
compared to CR non-participants. The angina frequency
domain was also higher (indicating less angina) in the CR
patients, however this was not statistically significant.
Consistent with this, scores on the SF-36 PCS tended to
be higher in the CR patients. In addition, elevated psycho-
social distress as identified by the SF-36 MCS, was lower
in the CR patients (Table 2).
Predictors of CR participation
Predictors of CR participation were assessed in the overall
group of patients presenting for angiography who were
potentially eligible for referral. Following univariate ana-
lysis, backward elimination retained the following predic-
tors: age, recent myocardial infarction and a prior history
of musculoskeletal disease. In the final model, only
recent myocardial infarction (OR = 2.8, 95% CI 1.5-5.3,
p = 0.001) remained as a significant predictor of CR
participation.
Six month outcomes in study patients
Clinical outcomes
At 6 months following angiography, at which time the
CR patients had completed their rehabilitation programme,
there were no differences between groups in relation to
cardiac events (Table 3). Furthermore there were no
differences between groups in changes in medical therapy
or angina limitations as assessed via the CSCC system
(Table 3).
HRQoL indices
Figures 2 and 3 summarise the HRQoL indices over the
6-month period for the 2 study groups. The HRQoL in-
dices were measured at 1 and 6 months although at the
1-month assessment time point, only 70% (n = 46) of the
CR participants had commenced the program and none
had completed the 6-week program. By 6 months, all
the CR participants had completed the CR program. The
SAQ-derived physical limitation, angina frequency, and
quality of life scales all showed significant improvement
over the 6-month study period. Both study groups also
demonstrated statistically significant improvements in
the SF-36 PCS and MCS over the 6-month period. How-
ever, no differences were observed in the rate of improve-
ment from baseline over 6 months between the two groups
in SAQ and SF-36 scores (Figures 2 and 3). Furthermore,
cross-sectional analysis on the 1 and 6 month endpoints
revealed no significant differences for both the SAQ and
SF-36 scales between the two groups.
Discussion
This case–control study assessed the clinical characteristics
of patients with angiographically-documented CAD who
underwent CR and assessed their subsequent clinical and
B. Patients approached for consenting 
prior angiography N=2089 (50%)
A. Patients presenting for coronary 
angiography 2003-2007 N=4546
C. Patients consented into study 
N=1268 (60%)
Patients not eligible for CR due to 
absence of CAD (includes valvular 
disease, cardiomyopathy, 
pericarditis, non-obstructive CAD)
N = 440 (35%)
E. Patients Eligible for CR at 
Facility (residing within local health 
jurisdiction) N = 221 (27%)
CR Participants N=68 (31%) 
Responders at 6 Months N=107 
(71%)
F. Responders at 6 Months N=43 
(62%)
Patients not consented due to refusal, 
language barrier or illness 
N=849 (40%)
D.    Patients eligible for CR due to 
confirmed CAD N=828 (65%)
After hours/weekend cases not 
approached for consent N=430 (10%)
Short stay, acute transfer cases, no staff 
available for consent N=1,181 (26%)
Patients not eligible for CR at 
facility (residing outside local 
health jurisdiction) N=607 (73%)




Figure 1 Flow Chart Describing Patients Presenting for Coronary Angiography and Eligible for Cardiac Rehabilitation at the Queen
Elizabeth Hospital. Study flow diagram describing (a) the number of patients undergoing coronary angiography during the recruitment period,
(b) the number of patients who were approached for consent, (c) reasons for no consent and exclusion, (d) the number of patients with
confirmed CAD, (e) the number of patients who were eligible for CR program and (f) the response rate of CR participants and non-participants.
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from this study are (i) patients who undertake CR are
younger and most likely to have experienced a recent
myocardial infarction; and (ii) in the 6-month follow-up
period, all patients showed an improvement in HRQoL
indices independent of whether or not they had CR with
no significant incremental benefit found in those who did
have CR.
Patient selection for cardiac rehabilitation
Typically, CR has been targeted towards CAD patients
who have experienced a recent MI [17] or undergonerevascularisation therapies [18]. In this study, two-thirds
of the CR patients had experienced a recent ACS, and
this was the defining clinical characteristic of the cohort.
Although it is paramount that all patients with an ACS
be offered CR, it is equally important that stable patients
with documented CAD should be offered CR. Indeed, as
shown in our study, those who did not undertake CR
were more chronically disabled, older, more physically
disabled, more frequently identified with psychosocial
distress and more often had a history of chronic stable
angina (Table 1). Hence those who did not undertake
CR may potentially have benefited more than those who















Age (years) 153 65 ± 12* 68 60 ± 12** 221 63 ± 12
Female 153 31% 68 24% 221 29%
Current Smoker 148 18% 68 21% 216 19%
Ex-smoker 147 45% 68 34% 215 41%
Hypertension 152 63% 67 55% 219 61%
Diabetes Mellitus 149 33% 67 28% 216 31%




152 32% 68 32% 220 32%
Prior Revascularisation 153 28% 68 24% 221 27%
Cerebrovascular disease 149 10% 63 2% 212 8%
Chronic obstructive
pulmonary disease
149 28% 63 13%* 212 24%
Peripheral arterial
disease
149 7% 63 3% 212 6%
Gastroesophageal
disorders
149 41% 65 32% 214 38%
Musculoskeletal disease 149 14% 63 22% 212 17%




150 41% 66 65%** 216 49%
Chronic Stable Angina 150 55% 66 33%** 216 51%
Low Socioeconomic
status
153 24% 68 16% 221 22%
CCS II-IV at
Angiography
141 61% 63 51% 204 58%
** p < 0.01.
*p < 0.05, age adjusted.
Table 2 Baseline cardiac history & HRQoL characteristics
between CR participants and non-Participants
n No CR (n = 153) n CR (n = 68)
Pre-Angiography Cardioprotective Therapy
Anti-platelet 153 84% 68 82%
Beta-blockers 153 35% 68 19%
Statins 153 67% 68 66%
ACE-inhibitor 153 42% 68 40%
Angiotensin Receptor Blocker 153 18% 68 13%
Obstructive CAD Findings
Single Vessel Disease 153 29% 68 32%
Double Vessel Disease 39% 32%
Triple Vessel Disease 32% 35%
Initial Treatment Strategy
Medical Therapy 153 56% 68 41%
Coronary Angioplasty/stent 30% 43%
Coronary bypass graft 14% 16%
Seattle Angina Questionnaire
Physical Limitation 153 54±25 68 64±22*
Angina Stability 153 37±31 68 40±34
Angina Frequency 153 59±27 68 66±27
Treatment Satisfaction 153 90±16 68 89±18
Quality of Life 153 42±22 68 44±24
Short-Form 36
Physical Summary Score 153 34±11 68 38±11
Mental Summary Score 153 42±11 68 43±11
Elevated Psychosocial Distress 153 62% 68 47%*
*p < 0.05, **p < 0.01, age adjusted.
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into why patients did/did not participate in the Phase II
CR program, thus it may reflect a selection bias by the
health care system or patient choice.
Regardless of the reason, the findings of this study
suggest that patients with chronic stable angina need to
be targeted for enrolment to a CR program and this may
be best undertaken at the time of diagnostic angiog-
raphy. Targeting CR to patients undergoing revasculari-
sation therapies is important and will provide CR to
some chronic stable angina patients. However this study
showed that those who did not receive CR tended to be
managed with medical therapy (Table 2). Moreover, CR
in stable angina patients has been shown to be superior
to percutaneous coronary intervention in increasingexercise capacity and reducing hospital readmissions
[19]. Thus an active program to target CR for disabled
chronic stable angina patients needs to be considered.
The impact of cardiac rehabilitation on HRQoL
Improvement in HRQoL following CR has not been con-
sistently documented as highlighted in a meta-analysis,
which demonstrated that improvement in HRQoL with
CR was better than in controls in only two of 12 trials
[4]. However, comparing HRQoL findings in CR re-
search is difficult due to the diversity of the instruments
used. Earlier studies often used psychosocial well-being
measures [5,6,20] rather than established generic and
disease-specific instruments. Although more recent trials
have increasingly employed the SF-36, there are still
conflicting accounts concerning the influence of CR on
HRQoL [21-24]. In addition, only few studies have
used a disease-specific measure, however the choice
of instrument has varied, and have included the Mac-
New [25,26], the Cardiac Quality of Life Index [27],
Table 3 Clinical progress over 6 months following
angiography
n No CR n CR n Total p
% % % Age
adjusted
CCS Class II-IV 6
Months
78 17% 34 21% 112 18% 0.593
Medication Changes
Any Changes 126 68% 60 68% 186 68% 0.965
Started Nitrates 125 22% 60 25% 185 23% 0.562
Started CCB 126 22% 60 13% 186 19% 0.165
Started Beta Blocker 126 14% 60 13% 186 14% 0.929
Started Any
Anti-anginal




128 16% 59 10% 187 14% 0.263
Chest pain
re-admission
127 16% 59 10% 186 14% 0.345
Myocardial infarction 127 2% 59 0% 186 2%
Repeat angiography 127 4% 59 3% 186 4% 0.646
PCI 126 13% 60 20% 186 15% 0.401
CABG 126 24% 59 22% 185 23% 0.905
Mortality 153 2% 68 1% 221 2% 0.844
MI/Mortality 153 3% 68 1% 221 3% 0.659
Figure 2 A-D. SAQ Domain Scores Over Six Months in CR Participants
months compared between cardiac rehabilitation participants and non-par
the rate or extent of improvement in the scores between CR participants a
Tavella and Beltrame BMC Health Services Research 2012, 12:406 Page 6 of 9
http://www.biomedcentral.com/1472-6963/12/406and Quality of Life after Myocardial Infarction [28].
Hofer et al [29] highlights that a consistent applica-
tion of a single disease-specific measure is warranted
in CR research. Although the SAQ is an established
and arguably the best disease-specific measure for
CAD [13], the present study is the first to utilize the
SAQ in a CR setting.
Study implications for cardiac rehabilitation
The failure of CR to impact on HRQoL in this and other
studies warrants further consideration as it may reflect
nuances relating to these studies rather than CR being
ineffective. These include factors relating to the patient,
the CR therapy and the study design.
Patient factors
As discussed above and reported in previous studies [30],
the patients who did not participate in CR were the most
disabled and thus may well have been those that would
have derived the most benefit. Five patient-related factors
may have influenced the findings in this study and should
be closely considered in further studies. Firstly, CR efficacy
in relation to impact on HRQoL has been shown to be
age-dependent with previous studies reporting that
younger (i.e. <41 years) and older (>65 years) patients
benefitting the most from CR with no benefits observed in
those 41–65 years [21,29]. In this study, the average age of
the CR participants was 60 years, which may have influ-
enced the findings. Secondly, almost half of the CR
patients were identified as experiencing elevatedand Non-Participants. SAQ domain scores from baseline to six
ticipants. Longitudinal analysis revealed no significant differences in
nd non-participants.
Figure 3 A and B.SF-36 Summary Scores Over Six Months. SF-36
Physical (A) and Mental Summary Score (B) from baseline to six
months compared between cardiac rehabilitation participants and
non-participants. Longitudinal analysis revealed no significant
differences in the rate or extent of improvement in the scores
between CR participants and non-participants.
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HRQoL. Thus if the CR program also focused on the
treatment of psychosocial distress, an incremental im-
provement in HRQoL may have also been achieved.
Thirdly, the CR study population predominantly under-
went this therapy following a recent myocardial infarct.
Muller-Nordhorn et al [21] showed that only patients
undergoing CR following revascularisation procedures
showed improvement in their SF-36 scores whereas recent
myocardial infarct patients did not. Fourthly, patient par-
ticipation in CR was 31%, which is comparable to rates
reported by other studies, which have shown 14-43% of
potential cardiac patients participate in CR programs [31-
33]. Although all the study patients were eligible for CR,
why the non-participants did not avail themselves to this
opportunity is unclear. The focus by the health workers
on the acute presentation [34,35] may have under-
emphasized the importance in chronic conditions andthus education of both health care workers and patients is
required. Logistic factors may have also influenced patient
participation, such as transport availability/cost and session
times. Finally, although all the CR patients completed the
program, the commitment they made to the therapy was
not assessed.The CR therapy
CR programs are heterogeneous in content although
professional societies are developing guidelines with core
components to standardize the therapy [36,37]. Hence
the findings from this study may not be applicable to
other CR programs. In particular, tailored programs for
different CAD presentations or populations may be
useful to maximize benefits for patients, as suggested by
Piepoli et al [38]. For example, tailored gender-specific
programs have been shown to provide increased quality
of life improvement for women [39]. Other aspects that
require further considerations include CR program
delivery and duration. The hospital-based CR program
in this study may be better delivered as a telephone or
on-line program, which may assist in patient participation
and provide long-term access to all. This is important
since recent studies have shown that a continued interven-
tion following CR is effective in improving cardiovascular
outcomes [40,41]. Also the duration of the CR program in
this study was only 6 weeks whereas Piepoli [38] highlights
that such short-term approaches are unlikely to yield
long-term benefits or impact on quality of life.Study design
The current study was a longitudinal case–control
design and the limitations of this design may have
influenced the findings. Firstly, the non-randomised
allocation to CR therapy may have been influenced by a
selection bias although the two groups were similar in
their baseline HRQoL indices. Secondly, the study period
was limited to 6 months and longer follow-up periods
may have influenced the results. Of note, a meta-analysis
of CR therapies showed improvement in all-cause
mortality only at 3-year follow-up and not earlier [42].
Thirdly, important information such as referral and drop
out rates, reasons for non-inclusion in CR, such as
ambulation, were not available in this study. The lack of
standardized data collection and thus insufficient program
information causes difficulty when assessing biases [43].
Lastly, although the study was powered to detect a
difference of 6 points on the SF-36 PCS, the total sample
size was relatively small; larger studies are required and
should investigate smaller but clinically relevant differences
in HRQoL. It should also be noted that HRQoL assessment
is best undertaken by patient interview where possible as
opposed to mail-out surveys to increase response rate.
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The importance of CR in reducing cardiac events
amongst patients with established CAD has been previ-
ously established, however its benefit in improving
HRQoL is less clear and has not been affirmed in this
study. This study has shown that those CAD patients
who do not undergo CR are usually more disabled with
chronic disorders and thus may potentially be those who
would derive the most benefit from this therapy. Thus
further studies are required to identify which patients
will receive the optimal benefit from CR therapy rather
than simply targeting those who have experienced a
recent ACS.
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